Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support

Elon Musk, the Tesla multi-billionaire investor and owner of the largest portion of Twitter TWTR shares has been discussing psychedelics on the social platform.
The most recent message Musk posted was a reply to a statement by Doug Drysdale, CEO of Cybin CYBN, the biotech company focused on progressing psychedelics to therapeutics by engineering proprietary drug discovery platforms and treatment for mental health disorders.


Drysdale’s original statement was a call for investors to consider the psychedelic market, as the potential of these substances could massively reduce the massive cost of mental health treatments.

"Have you looked at the pharmacoeconomic potential of psychedelics to massively reduce the $2.5T cost of mental health? Wall Street is missing out," Drysdale said.

Musk’s Tweet was also a reply to TV host Jim Cramer, another supporter of psychedelics who dedicated one of his shows last year to the subject of major depressive disorder.

"Tremendous love and awe for Elon Musk out here in SF. Just awe," said Cramer in a Tweet.

This week Joe Rogan lashed out at the U.S. Customs and Border Protection agency (CPB) for a recent seizure of American tourists returning to the U.S. with marijuana, psilocybin and MDMA in their vehicle.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksPsychedelicsMarketsDoug DrysdaleElon MuskJim CramerJoe Rogan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.